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Objectives: Indigenous Latin American populations have used extracts from
Calophyllum brasiliense, a native hardwood, to treat gastrointestinal symptoms for
generations. The hexane extract of Calophyllum brasiliense stem bark (HECb) protects
against ethanol-mediated gastric ulceration in Swiss–Webster mice. We investigated
whether HECb inhibits the development of gastric epithelial pathology following
Helicobacter felis infection of INS-Gas mice.
Materials and Methods: Groups of five male, 6-week-old INS-Gas mice were
colonized with H. felis by gavage. From 2 weeks after colonization their drinking water
was supplemented with 2% Tween20 (vehicle), low dose HECb (33 mg/L, lHECb) or high
dose HECb (133 mg/L, hHECb). Equivalent uninfected groups were studied. Animals
were culled 6 weeks after H. felis colonization. Preneoplastic pathology was quantified
using established histological criteria. Gastric epithelial cell turnover was quantified by
immunohistochemistry for Ki67 and active-caspase 3. Cytokines were quantified using
an electrochemiluminescence assay.
Results: Vehicle-treated H. felis infected mice exhibited higher gastric atrophy scores
than similarly treated uninfected mice (mean atrophy score 5.6 ± 0.87 SEM vs.
2.2 ± 0.58, p < 0.01). The same pattern was observed following lHECb. Following
hHECb treatment, H. felis status did not significantly alter atrophy scores. Gastric
epithelial apoptosis was not altered by H. felis or HECb administration. Amongst
vehicle-treated mice, gastric epithelial cell proliferation was increased 2.8-fold in infected
compared to uninfected animals (p < 0.01). Administration of either lHECb or hHECb
reduced proliferation in infected mice to levels similar to uninfected mice. A Th17
polarized response to H. felis infection was observed in all infected groups. hHECb
attenuated IFN-γ, IL-6, and TNF production following H. felis infection [70% (p < 0.01),
67% (p < 0.01), and 41% (p < 0.05) reduction vs. vehicle, respectively].
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Conclusion: HECb modulates gastric epithelial pathology following H. felis infection
of INS-Gas mice. Further studies are indicated to confirm the mechanisms underlying
these observations.
Keywords: Helicobacter, preneoplasia, chromanones, chemoprevention, stomach neoplasms
INTRODUCTION
Gastric cancer is the third commonest cause of cancer death
worldwide (Ferlay et al., 2013). Over 80% of patients with
primary gastric adenocarcinoma have evidence of prior exposure
to Helicobacter pylori. Curative treatment for gastric cancer relies
on surgical or endoscopic resection of lesions, however, many
patients present late in the disease process and hence cannot be
offered curative therapy.
Established chemotherapeutic agents are available for patients
with gastric cancer, but their efficacy is limited (Bauer et al.,
2015). Another strategy that could be employed to reduce the
burden of gastric cancer would be to develop chemopreventative
strategies that retard the development of gastric cancer in at risk
populations. Currently the only effective treatment strategy to
achieve this is to eradicate H. pylori, but this strategy is becoming
more challenging due to the emergence of antibiotic resistant
organisms (Shiota et al., 2015), and is relatively ineffective
in people who have established preneoplastic pathology (Ford
et al., 2014), therefore novel therapeutic agents are needed.
As 70% of novel chemotherapeutic agents are derived from
plant materials (Newman and Cragg, 2012), the extraction and
characterization of novel, naturally occurring compounds is an
important strategy for the identification of potentially important
new drugs.
Calophyllum brasiliense Cambessédes is a tropical hardwood
tree of the Calophyllaceae family native to Latin America’s
rainforests (Mesia-Vela et al., 2001; The Angiosperm Phylogeny
Group, 2016). Many parts of this tree, including the latex that
exudes from its bark, have been used in folk medicine to treat
a variety of symptoms, including those associated with the
gastrointestinal tract (Corrêa, 1978; Reyes-Chilpa et al., 2006;
Neto, 2012). The hexane extract of C. brasiliense stem bark
(HECb) has been shown to protect against models of acute gastric
ulceration in Swiss–Webster mice and Wistar rats. The majority
of this extract is composed of two chromanones, Brasiliensic
acid and Isobrasiliensic acid, these agents have been shown to
contribute at least part of the gastroprotective activity of HECb
(Lemos et al., 2012).
As HECb and its chromanone fractions influence the
development of gastric ulceration, we hypothesized that these
agents may also influence the outcome of chronic Helicobacter
infection, and may modulate the development of gastric
cancer. To determine whether this is the case we adopted the
established INS-Gas mouse/H. felis induced gastric pre-neoplasia
model. In this model, constitutively hypergastrinaemic INS-
Gas mice are colonized with H. felis for 6 weeks. Animals
develop marked gastritis with atrophy and early pre-neoplastic
lesions identifiable in the gastric corpus of infected mice
(Wang et al., 2000; Thomson et al., 2012; Burkitt et al.,
2017). We have used this model to characterize how HECb
administration influences gastric pre-malignancy and gastric cell
turnover.
MATERIALS AND METHODS
Botanical Material
The stem bark of C. brasiliense Cambess. was collected in June
2010 by LMSL (authorization number 22698-1 Ministério do
Meio Ambiente, Brazil), at the source of the Coxipó River
(S15◦38′40.8′′, W056◦03′05.6′′), Cuiabá, MT, Brazil. A voucher
specimen (# 37993) was deposited at the Herbarium of Federal
University of Mato Grosso (UFMT), Brazil, and was identified by
Harri Lorenzi M.Sc., Instituto Plantarum de Estudos da Flora,
Nova Odessa, SP, Brazil. The preparation of HECb, as well as
brasiliensic (Bras. acid) and isobrasiliensic acid (Isobras. acid)
isolation process, were as previous described (Lemos et al., 2016).
Animals
All animal procedures were performed at the University of
Liverpool with UK Home Office approval. In vivo experiments
were performed in male INS-Gas mice on the FVB/N (Wang
et al., 1993) background bred and maintained at the University
of Liverpool Biomedical Services Unit. Primary gastric gland
cultures were generated from male C57BL/6 mice acquired from
Charles River, Margate, UK.
Helicobacter felis Colonization
Experiments
Helicobacter felis (ATCC 49179) was cultured for 72–96 h at
37◦C on Columbia chocolate agar plates in a microaerophilic
environment generated by Campygen atmosphere generating
packs in an anaerobic jar (all Oxoid, Basingstoke, UK).
For colonization of mice, the organism was harvested into
tryptone soy broth and bacterial density was estimated by
optical density at 600nm. An estimated bacterial density
in excess of >108 CFU/mL was required to progress to
gavage.
Groups of at least five male INS-Gas aged 6 weeks were
administered 0.5 ml H. felis suspension by oro-gastric gavage on
three occasions over one week. Successful H. felis colonization
was confirmed 2 weeks after the final gavage procedure
by quantitative PCR for FlaA in fecal DNA (Duckworth
et al., 2015b). At this time, drinking water was supplemented
with 2% Tween 20, HECb 33 mg/L (lHECb, approximately
10 mg/kg/day) or HECb 133 mg/L (hHECb, approximately
40 mg/kg/day) and made available ad-libitum. Equivalent
uninfected control groups were also studied. Animals were culled
by cervical dislocation 6 weeks after H. felis colonization. Corpus
and antrum mucosal samples were taken for histopathology
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and immunohistochemistry studies. The remainder of gastric
tissue was homogenized in PBS with protease inhibitor for
quantification of cytokines by electrochemiluminescent assay.
Histological Procedures
Gastric tissues were fixed in 4% formalin in PBS for a minimum
of 12 h, processed into paraffin wax embedded blocks by
standard methods and sectioned at 4 µm thickness for all
staining techniques. Corpus and antrum were stained with
hematoxylin and eosin (HE) for histopathological evaluations.
Immunohistochemical analysis of corpus was also performed.
Immunohistochemistry
Gastric corpus mucosa was labeled by immunohistochemistry
for proliferation (Ki67 primary antibody, AbCam, Cambridge,
UK), apoptosis (cleaved caspase 3, AF835, R and D Systems,
Minneapolis, MN, USA), and tyrosine 204 phosphorylation
state specific ERK (sc-7383, SantaCruz Biotechnology,
Dallas, TX, USA) by immunohistochemistry. All primary
antibodies were raised in rabbit and were visualized
using the Impress HRP system (Vector laboratories,
Peterborough, UK).
Quantitative Histological Methods
Histological tissue sections were scored by an investigator
blinded to sample identity, using a modified visual analog scale
(Rogers, 2012). To quantify cell numbers in the gastric corpus
mucosa, 10 areas per mouse, with well oriented gastric glands,
forming a well visualized epithelial monolayer were chosen. Ki67
scoring was performed using a 10 mm × 10 mm eyepiece
graticule divided into 1 mm squares which was overlapped along
the chosen area using a ×40 objective. Number of positive cells
per square were recorded as previously described (Burkitt et al.,
2013). Apoptotic and ERK phosphorylation events were scored
by examining the number of positively stained cells in 10 high
powered fields per section, using a×63 objective. All results were
expressed as mean± SEM.
Electrochemiluminescence
Immunoassay Analysis
Twelve cytokines were measured in the same samples of gastric
homogenate of mice infected or not with H. felis by multiplexed
electrochemiluminescence cytokine immunoassays (Meso Scale
Discovery, Gaithersburg, MD, USA). Specifically, these were a
Th1/Th2 standard 10-plex panel consisting of IFN-γ, IL-1β,
IL-2, IL-4, IL-5, KC-GRO, IL-10, IL-12 p70, IL-13, and TNF.
In addition, simplex IL-17 and IL-23 assays were performed
in parallel, as Th17 responses are strongly associated with
Helicobacter infections. The part of the stomach between corpus
and antrum of H felis infected and uninfected INS-Gas mice was
homogenized twice in PBS with protease inhibitors (SigmaFast,
Sigma–Aldrich, UK), using the TissueLyserII (QIAGEN, Tokyo,
Japan) at 25 Hz for 3 min. After centrifugation (4◦C, 12,000 rpm,
10 min), supernatants were transferred to a clean tube, and stored
at −80◦C until use. Immediately before analysis, samples were
clarified by further centrifugation (4◦C, 12,000 rpm, 10 min).
Electrochemiluminescence analysis was performed according
to the manufacturer’s instructions. A standard curve for each
analyte was curve-fitted and allowed determination of the
concentration in pg cytokine/mL.
Murine Primary Gastric Gland Cultures
Gastric epithelial cultures were generated as previously described
(Duckworth et al., 2015a) and were maintained in 12-well
tissue culture plates on glass cover slips (Appleton Woods,
Selly Oak, UK) that contained 1.0 mL/well DMEM-Ham’s
F-12 mix (Sigma–Aldrich), 10% fetal calf serum (Invitrogen,
Paisley, UK), 1.25% L-glutamine (Sigma–Aldrich), and 1%
antibiotic/antimycotic mixture (Sigma–Aldrich). Following
digestion and plating, glands were maintained at 37◦C
in a humidified environment containing 5% CO2 for
24 h. Media was changed to fresh complete media after a
further 24 h. Forty-eight hours after initial plating, cells
were treated with HECb, brasiliensic and isobrasiliensic
acids (12.5 to 100 µg/mL) for 24 h, 2 h before fixation
EdU was added to the culture media. Cells were fixed in
2% formaldehyde for 30 min followed by three washes in
PBS. Treatments were repeated a minimum of four times
using glands extracted from a different mouse on each
occasion.
Immunofluorescence
Primary glands were immunolabeled for cleaved caspase 3 and
EdU. Two hours before the end of treatment, 200µL of treatment
media was replaced by 200 µL of 10 µM EdU and incubated
to complete the treatment. Cultures were washed and fixed with
2% paraformadehyde in PBS for 30 min. Following fixation,
EdU intercalation was labeled using the Click-iT EdU Alexa
Fluor 594 Imaging Kit (Invitrogen, Paisley, UK) as per protocol.
Subsequently non-specific protein binding was blocked with 10%
goat serum and apoptotic cells were labeled with a rabbit anti-
cleaved caspase 3 antibody (AF835, Cell Signalling, Beverly,
MA, USA) and visualized with Alexa fluor 488 conjugated
donkey anti-rabbit immunoglobulins (Invitrogen). Coverslips
were mounted with Vectashield with DAPI (Vector Labs). Slides
were observed using a standard Nikon fluorescent microscope,
and proliferative and apoptotic events were quantified as
previously described (Duckworth et al., 2015a).
Human Gastric Cancer Cell Culture
The human gastric adenocarcinoma cell line AGS (ATCC CRL
1739) were grown in complete medium, consisting of Dulbecco’s
Modified Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum, 1% L-glutamine and 1% penicillin/streptomycin at
37◦C in 5% CO2 atmosphere with humidity.
Flow Cytometry
AGS cells (106 cells/well) were seeded in 12-well plates, then
treated or not with HECb, brasiliensic, and isobrasiliensic acids
(12.5, 25, and 50 µg/mL) for 24 h. Cells were harvested,
washed with phosphate-buffered saline (PBS), fixed with cold
70% ethanol and kept at –20◦C until use. Cells were washed
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three times with PBS and stained with a solution of ribonuclease
A (R4875, Sigma–Aldrich, Sao Paulo, BR, USA) at 50 µg/mL
and propidium iodide (P4170, Sigma–Aldrich, Sao Paulo, BR,
USA) at 20 µg/mL in PBS for 90 min, cell cycle distribution was
determined by flow cytometric analysis using a BD AccuriTM C6
(BD, Piscataway, NJ, USA).
Western Blotting and Blot Densitometry
AGS cells (2 × 106 cells/well) were seeded in 6-well plates,
pretreated with HECb (12.5, 25, and 50 µg/mL) and a highly
selective MEK1 inhibitor (PD98059) at 10 mM for 24 h. Cultures
were subsequently infected with H. pylori at a MOI of 300:1 for
1 h. After incubation, cells were lyzed in ice-cold RIPA buffer
supplemented with protease cocktail and phosphatase inhibitors
(Sigma Fast, 10 mM sodium orthovanadate, 10 mM sodium
pyrophosphate, and sodium fluoride 100 mM).
Protein lysates were subjected to SDS-PAGE before being
immobilized onto nitrocellulose membranes (Biorad, USA).
After transfer, membranes were blocked (20 mM Tris-HCl, pH
7.4, 125 mM NaCl, 0.2% Tween 20, 1% bovine serum albumin, 3%
non-fat milk) for 1 h at room temperature and incubated for 4 h
at 4◦C with specific primary antibodies: p-ERK1/2 and β-actin (as
above, Santa Cruz Biotechnology, Dallas, TX, USA). Blots were
incubated with secondary antibody rabbit anti-mouse IGG-HRP
(sc-358914, Santa Cruz Biotechnology, Dallas , TX, USA) and
immunoreactive bands were visualized by chemiluminescence
(ECL Amersham, USA) and detected with ChemiDoc XRS
systemTM software and subsequently analyzed with Image LabTM
(Biorad, Irvine, CA, USA).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6
software. Data represent mean ± SEM. Comparisons were made
using 1-way or 2-way ANOVAs and Tukey’s or Sidak’s post hoc
analysis as appropriate. p < 0.05 was considered significant.
RESULTS
HECb Protects against H. felis Induced
Pre-neoplasia in INS-Gas Mice
To determine whether the administration of HECb affected the
outcome of H. felis induced gastric pre-neoplasia, groups of five
6-week old male INS-Gas mice were infected with H. felis by oro-
gastric gavage, two weeks later drinking water was supplemented
with hHECb, lHECb, or vehicle (2% Tween 20). This treatment
was maintained until the end of the procedure 6 weeks after
the final dose of H. felis. At the end of the procedure, animals
were culled and gastric epithelial tissues prepared for quantitative
histopathology and electrochemiluminescent cytokine analysis.
Control groups that underwent changes to their water supply, but
did not receive H. felis were also maintained.
Pathological gastric lesions were quantified using an
established visual analog scoring tool. Uninfected animals
had low combined pathology scores (mean score 2.2 ± 0.58),
with no significant differences observed in mice exposed to
HECb compared to those receiving vehicle. The administration
of H. felis led to the development of marked gastric corpus
pathology in the vehicle group (5.6 ± 0.87). lHECb appeared
to have no impact on development of gastric corpus neoplasia
at this timepoint, with similar composite pathology scores
(7.2 ± 0.37) compared to vehicle treated, H. felis infected
mice. In contrast, composite pathology scores were partially
attenuated in animals co-administered hHECb (4.0 ± 0.45)
(Figures 1A,B). At this time-point, treatment with HECb
had no discernable effect on inflammatory cell infiltration or
parietal cell loss (Figures 1C,D), however, the gastric mucosa
was 1.9 times thicker in vehicle treated H. felis infected mice
compared to vehicle treated uninfected mice (p< 0.05). In HECb
treated mice H. felis infection did not significantly alter mucosal
thickness (Figure 1E), and mucous metaplasia was decreased on
morphological scoring criteria in H. felis infected mice receiving
hHECB (Figure 1F).
To further characterize the gastric epithelial immune response
to H. felis infection in this model mucosal cytokine abundance
was determined by electrochemiluminescent assay. Colonization
with H. felis induced a Th17 polarized immune response, as
previously demonstrated in this and other mouse models of
Helicobacter induced gastric pre-neoplasia (Figures 2A,B).
Administration of either vehicle or HECb did not alter this
overall response, however, there were subtle changes in the
abundance of individual cytokines. Amongst H. felis infected
mice IFN-γ, TNF, and IL-6 were all less abundant (3.3-fold,
3.1-fold, and 1.7-fold, respectively) in animals administered
hHECb compared to those treated with vehicle. Treatment
with lHECb also induced an apparent, though statistically not-
significant, reduction in IFN-γ and IL-6 abundance, supportive
of a dose response effect for HECb on production of these
cytokines. lHECb had minimal impact on TNF abundance
compared to vehicle (Figures 2C–E). The abundance of KC-
GRO, a mouse homolog for IL-8, in vehicle treated mice
was 10.9-fold more abundant in mice colonized with H. felis,
compared to the uninfected group, this cytokine was unaffected
by the administration of HECb (Figure 2F). These observations
suggest that treatment with HECb minimally attenuates the
inflammatory response induced by H. felis.
HECb Influences Gastric Epithelial
Remodeling by Altering Epithelial Cell
Turnover in Response to H. felis In vivo
The observation that H. felis induced metaplasia was less
abundant in mice treated with hHECb led us to hypothesize
that HECb treatment might influence epithelial remodeling,
either impacting de-differentiation of mature cell lineages,
or influencing epithelial cell turnover. To characterize this,
quantitative histology was used to determine the number of Ki67
positive proliferating cells (Figure 3A), and cleaved caspase 3
positive (Figure 3C) apoptotic cells in the gastric corpus mucosa
of mice.
A mean apoptotic index of 3.8 (±0.53) cells per high powered
field (hpf) was demonstrated in vehicle treated, uninfected
mice. This did not change significantly following H. felis
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FIGURE 1 | Evaluation of gastric corpus pathology of INS-Gas mice infected or not with Helicobacter felis for 6 weeks and treated with 33 mg/L
(lHECb) or 133 mg/L (hHECb) ad libitum for the final 4 weeks. (A) Representative photomicrographs of HE-stained sections of gastric corpus, scale
bar = 50 µm. Histopathologic scoring results of (B) composite atrophy pathology (C) inflammation (D) oxyntic gland atrophy (E) mucosal thickness, and (F)
metaplasia. Two-way ANOVA followed by Sidak’s multiple comparison post hoc test. All data are mean ± SEM of five mice. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001,
∗∗∗∗p < 0.0001 vs. uninfected mice with the same treatment.
FIGURE 2 | Effect of hexane extract of Calophyllum brasiliense stem bark (HECb) on cytokine abundance in homogenate from the stomachs of
INS-Gas mice infected or not with H. felis for 6 weeks and treated with 33 mg/L (lHECb) or 133 mg/L (hHECb) ad libitum for the final 4 weeks, by
electrochemoluminescence assay. (A) Th1 and Th17 ratio response, abundance of (B) IL-17, (C) IFN-γ, (D) TNF, (E) IL-6, and (F) KC-GRO in gastric tissue.
Two-way ANOVA followed by Tukey’s multiple comparison post hoc test. All data are means ± SD of 5 mice. ∗p < 0.05, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 vs.
uninfected mice with the same treatment, θθp < 0.01 vs. Tween 20 control group with the same infection status.
infection, or administration of HECb (Figure 3D). In contrast
H. felis infection had a profound impact on abundance of Ki67
immunopositive cells. Uninfected mice treated with Tween20
had a proliferation index of 20.5 (±3.2), which was similar to
the proliferation index of uninfected mice treated with HECb.
Following H. felis infection vehicle treated mice exhibited a 2.8-
fold increase in proliferative index (p < 0.01, Figure 3B). When
HECb was administered at either dose Ki67 abundance was
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FIGURE 3 | Effect of HECb on cell turnover in gastric corpus of INS-Gas mice infected or not with H. felis for 6 weeks and treated with 33 mg/L
(lHECb) or 133 mg/L (hHECb) ad libitum for the final 4 weeks. (A) Representative photomicrographs of proliferating cells immunostained with Ki67 and (B)
graph showing Ki67 positive cells scored, scale bars 50 µm (C) representative photomicrographs of apoptotic cells immunostained for cleaved caspase-3 and (D)
graph showing the number of cleaved caspase 3 positive cells per high powered fields. Two-way ANOVA followed by Tukey’s multiple comparison post hoc test. All
data are mean ± SEM of five mice. ∗∗p < 0.01 vs. uninfected mice with the same treatment, θp < 0.05 vs. Tween20 control group with the same infection status.
significantly lower in infected mice compared to vehicle treated
controls (2.3-fold and 2.2-fold reductions for hHECb and lHECb,
respectively, p < 0.01), leading to proliferation indices similar to
those seen in uninfected mice.
HECb Induced Suppression of
Proliferation is an Epithelial Cell Event
To determine whether the anti-proliferative effect of HECb
observed in H. felis infected INS-Gas mice was driven purely
by its apparently modest influence on inflammation, or through
an immune cell independent mechanism, primary cultures of
murine gastric glands were generated. In our hands these cultures
can be maintained for in excess of 5 days, and have previously
been shown to contain cells of each of the major gastric epithelial
lineages (Duckworth et al., 2015a).
Cultures were generated from male C57BL/6 mice. On the
third day of culture, gastric glands were treated with rising
concentrations of HECb or its constituents, brasiliensic acid,
and isobrasiliensic acid. Cells were fixed at 24 h. Epithelial
cell proliferation was assayed by quantifying the percentage
of cells that had intercalated EdU, apoptosis was quantified
by immunofluorescence for cleaved caspase-3. Each treatment
was performed on cultures derived from four individual
mice.
In untreated cultures, 8.2% (±0.58) of cells intercalated
EdU into their DNA. At different doses of treatment with
HECb, brasiliensic acid, and isobrasiliensic acid all suppressed
proliferation (Figures 4A–C). Significant suppression of
proliferation was observed following treatment with HECb at
doses in excess of 25µg/mL. Brasiliensic acid partially suppressed
proliferation at 12.5 µg/mL and had more pronounced effects
at doses in excess of 25 µg/mL. Isobrasiliensic acid suppressed
proliferation at doses of 50 µg/mL and 100 µg/mL.
All three compounds also induced apoptotic responses.
Cytotoxicity in this model occured following treatment with
100 µg/mL of HECb or Brasiliensic acid. 100 µg/mL HECb
induced a 13.3-fold increase in apoptosis compared to untreated
glands (42% apoptotic cells, p < 0.001), whilst 100 µg/mL
Brasiliensic acid triggered 55% (p < 0.0001) of cells to become
apoptotic. Isobarasiliensic acid treatment induced apoptosis at
both 50 µg/mL and 100 µg/mL with, respectively, 31 and
52% of cells shown to be apoptotic (Figures 4D–F). These
observations demonstrate that HECb and its constituents induce
cell cycle arrest and apoptosis in untransformed epithelial cell
culture, suggesting that there is a direct epithelial effect of these
compounds.
To characterize whether the impact of HECb and its
constituents on gastric epithelial cell proliferation was an isolated
phenomenon in the ex-vivo culture setting, or whether the same
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FIGURE 4 | Effects of HECb on cell turnover of murine primary gastric epithelial cell cultures treated with HECb, brasiliensic acid or isobrasiliensic
acid (12.5–100 µg/mL) for 24 h, evaluated by immunofluorescence. Data expressed as percentage of proliferating cells following (A) HECb, (B) brasiliensic
acid, and (C) isobrasiliensic acid and percentage of apoptotic cells following (D) HECb, (E) brasiliensic acid, and (F) isobrasiliensic acid. Two-way ANOVA followed
by Tukey’s multiple comparison post hoc test. All data are mean ± SD n = 4. ∗∗p < 0.01 ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 vs. untreated cells.
effects are identifiable in transformed cell lines, the cell cycle
dynamics of AGS cells treated with HECb and its constituent
chromanones was characterized by propidium iodide FACS
analysis. Experiments were repeated a total of 4 times for each
treatment.
In untreated AGS cultures, 0.11% (±0.02 %) of cells were
identified in the pre-G1 apoptotic phase, 37.7% (±1.14%) were
in the G1 phase, 21.8 % (±2.52 %) of cells were in S phase and
35.7% (±1.7 %) were in G2M phase (Figure 5). No increase in
the proportion of cells in pre-G1 was observed when AGS cells
were treated with HECb or its constituents at 25 or 50 µg/mL.
This is in keeping with our findings in primary cell culture
where apoptosis was not induced when these concentrations were
tested.
Hexane extract of Calophyllum brasiliense stem bark (HECb)
significantly decreased the proportion of cells in S-phase at
both 25 and 50 µg/mL (9.9 and 8.3%, of cells in S-phase,
respectively, Figure 5A), with a reciprocal increase in proportion
of cells in G1 (45.5 and 54.9%, p < 0.05 and p < 0.0001
respectively for 25 and 50 µg/mL HECb). Brasiliensic acid
induced a similar reduction in percentage of cells in S-phase
at a dose of 50 µg/mL (13.0% of cells in S-phase, p < 0.01
Figure 5B), with an increase in proportion of cells in G1
observed (52.3%, p< 0.01). Both 25 and 50µg/mL isobrasiliensic
acid also reduced the proportion of cells in S-phase compared
to control (11.5 and 9.4% of cells in S-phase, respectively,
both p < 0.01 Figure 5C). Intriguingly, however, lower dose
isobrasiliensic acid induced an increase in proportion of cells
in G1 (52.9 %, p < 0.001), similar to that observed in cells
treated with either HECb or brasiliensic acid, whilst higher
dose isobrasiliensic acid appeared to induce G2M arrest with
an increase in the number of cells in this phase (45.4%,
p < 0.05).
These data demonstrate that HECb and its constituents are
capable of inducing cell cycle arrest in transformed cell lines.
The evidence that isobrasiliensic acid induced G1 arrest at low
dose and G2M arrest at higher doses attests to these compounds
potentially acting through more than one mechanism, dependent
upon the drug dosing regime.
HECb Suppresses Helicobacter Induced
Phosphorylation of ERK In vitro and
In vivo
To further characterize how HECb affects Helicobacter induced
proliferation, we pre-treated AGS cells with either HECb or the
MEK 1 inhibitor PD98025 for 24 h. Subsequently cells were co-
cultured with H. pylori at a multiplicity of infection of 300:1 for
1 h. A well characterized strain of H. pylori was used for these
asssays, rather than H. felis as the effects of this organism on
human cell culture are better characterized than those of H. felis,
and H. pylori infection is more relevant to human disease.
The abundance of p-ERK in whole cell lysates was quantified
by Western blotting. All experiments were repeated three times.
Blot densitometry was performed to quantify relative expression
of p-ERK compared to pan-actin abundance.
Exposure of AGS cells to H. pylori for 1h induced
phosphorylation of ERK 1 and 2. When cells were pre-treated
with HECb we observed significantly less phosphorylation of
ERK at all doses that were administered (Figures 6A,B).
To determine whether ERK phosphorylation was also
involved in the reduction of gastric epithelial cell proliferation
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FIGURE 5 | Effect of HECb and its constituents on cell cycle of transformed gastric epithelial cells. AGS cells were treated with HECb, brasiliensic acid, or
isobrasiliensic acid (25 or 50 µg/mL) or untreated for 24 h and stained with propidium iodide. (A) Shows representative plots from untreated and HECb treated cells
demonstrating the shift in distribution of cells by cell cycle phase folowing HECb administration. (B–D) Show the mean percentage of cells (±SEM) in PreG1, G1, S,
and G2M phases of cell cycle, HECb (B), brasiliensic acid (C) and isobrasiliensic acid (A). Two-way ANOVA followed by Tukey’s post hoc analysis. ∗p < 0.05;
∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001 vs. untreated cells in the same phase of cell cycle.
FIGURE 6 | Effect of HECb on Helicobacter induced phosphorylation of ERK in vitro and in vivo. AGS cells were pretreated with HECb (12.5–50 µg/mL) for
24 h, and infected with H. pylori (MOI 1:300) for 1 h. (A) p-ERK1/2 abundance relative to β-actin. One-way ANOVA, followed by Sidak’s post hoc test. Data are
mean ± SD n = 3. ∗∗∗∗p < 0.0001 vs. untreated, uninfected cells. (B) Representative western blotting. Phosphorylation was estimated in relation to the relative
amount of the endogenous β-actin control. Each line represents the mean of three independent experiments. (C) Effect of HECb on ERK1/2 phosphorylation in
gastric corpus of INS-Gas mice infected or not with H. felis for 6 weeks and treated with 33 mg/L (lHECb) or 133 mg/L (hHECb) ad libitum for the final 4 weeks.
Means ± SEM. N = 5. ∗∗∗p < 0.001 vs. uninfected mice with the same treatment, ##p < 0.01, ###p < 0.001 vs. Tween 20 control group with the same infection
status. (D) Representative photomicrographies of ERK1/2 immunostaining, scale bar = 25 µm.
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in response to H. felis infection, in vivo gastric corpus tissue
samples from mice infected with H. felis or not, and treated
with hHECb, lHECb or vehicle were immunostained for p-ERK.
The number of cells expressing p-ERK was determined by
quantitative immunohistochemistry.
The gastric corpus of vehicle treated, uninfected mice
exhibited 1.3 (±0.2) p-ERK positive cells per high power field.
Administration of HECb did not significantly influence this in
uninfected mice, however, administration of H. felis induced a
6.4-fold (p < 0.001) increase in p-ERK positive cells in mice
treated with vehicle. H. felis induced phosphorylation of ERK was
almost entirely suppressed by treatment with either of the tested
doses of HECb (Figures 6C,D).
This suggests that regulation of a classical MAPK pathway may
be targeted directly or indirectly by HECb administration both
in vitro and in vivo.
DISCUSSION
The data presented here provide further evidence that the
oral administration of HECb influences the outcome of gastric
epithelial injury. These effects were observed in the context of
minimal changes in inflammatory phenotype with only a modest
reduction in cytokine production in hHECb treated mice and no
difference in morphological inflammation. It therefore appears
likely that HECb acts predominantly through a protective effect
on the gastric epithelium. This is in keeping with previous studies
which demonstrated mucosal protection by HECb and some of
its fractions during stress or chemically induced gastric ulceration
(Sartori et al., 1999). In rats with ethanol induced gastric lesions
HECb administration led to the inhibition of malondialdehyde
and catalase activity suggesting that this gastroprotective role is,
in part, due to an antioxidant effect (Lemos et al., 2012).
The mechanism by which HECb influences gastric epithelial
homeostasis remains incompletely understood, however, we
have now shown that it suppresses proliferation in gastric
epithelial cells both in untreated primary cell culture and in
transformed cell lines. In addition, we have shown that H. felis
induced proliferation is suppressed in vivo by this compound.
In vitro we also demonstrated marked gastric epithelial cell
cytotoxicity at higher doses of HECb (100 µg/mL). However,
at doses used in vivo this was not observed, suggesting that
effective pharmacological doses probably did not reach this toxic
concentration.
To understand how HECb influences proliferation at a
molecular level we have characterized the phosphorylation of
ERK. ERK is phosphorylated in response to Helicobacter co-
culture in vitro, whilst administration of HECb suppresses
Helicobacter associated phosphorylation of ERK. In vivo we
also observed marked suppression of Helicobacter induced
phosphorylation of ERK when mice were treated with HECb.
This suggests that HECb interacts with the Ras-Raf-MEK-ERK
pathway, though it remains unclear whether this is through
direct interaction with a pathway member, or whether this effect
is secondary to interaction with upstream regulators of the
pathway. Further mechanistic studies aiming to characterize the
precise interaction of HECb and its constituents with mammalian
proteins are indicated to enable us to understand the mechanism
of action of this extract.
Due to the complexity of extracting the constituent
chromanones from HECb it has not been possible to characterize
the effects of either brasiliensic or isobrasiliensic acids on murine
pre-neoplastic pathology. However, observations from ex vivo
and in vitro cell culture models suggest that both of these
agents are able to influence gastric epithelial cell turnover. In
untransformed cells, brasiliensic acid appeared to have the widest
potential therapeutic window where epithelial cell proliferation
was suppressed, but apoptosis had not been induced (between
12.5 and 100 µg/mL), however, the effect of these doses of
brasiliensic acid on the proliferation of transformed cell lines
was more modest, and isobrasiliensic acid at doses of 25 and
50 µg/mL were required to induce cell cycle arrest. In this
model an increase in apoptosis was not observed at the tested
doses. Intriguingly we also demonstrated that high doses of
isobrasiliensic acid induced a G2M cell cycle arrest as opposed
to the G1 arrest observed following administration of either low
dose isobrasiliensic acid, or HECb or brasiliensic acid at any dose
tested.
Chromanones synthesized or extracted from diverse sources
have previously been assessed and shown to exhibit diverse
pharmacological functions [including antimicrobial (Xu et al.,
1998; Kanokmedhakul et al., 2002; Cottiglia et al., 2004; do
Nascimento et al., 2007; Tanaka et al., 2009), anti-oxidant (Lee
et al., 2005) and anti-inflammatory effects (Konieczny et al.,
1976), as well as effects on cardiac muscle repolarization (Wang
et al., 2014) and coronary artery vasodilation (Nagao et al., 1972)].
This diversity of pharmacological activity supports our cell-cycle
data which may suggest divergent mechanisms of action for
brasiliensic and isobrasiliensic acids at higher doses.
The differences in drug doses that induce apoptosis and cell
cycle arrest suggest that there may be therapeutic windows in
which these compounds could be used to induce gastric cell
cycle arrest without inducing cytotoxicity. These findings support
the need for further studies to investigate whether HECb and
its constituents may influence the process of human gastric
carcinogenesis.
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